Company Overview of OptiNose AS
OptiNose AS, a drug delivery company, offers research and development for nasal drug and vaccine delivery devices for pharmaceutical and biotech companies. The company offers single and multi-use intranasal delivery devices for liquid and powder formulations. Its nasal drug delivery devices enable nasal administration of central nervous system, systemic, and topical nasal formulations; and breath actuated devices deliver intranasal drugs to targeted regions of the nasal cavity, including the sinuses and olfactory regions. OptiNose AS was founded in 2000 and is based in Oslo, Norway.
Austliveien 1 Røa
Founded in 2000
47 22 51 59 00
47 22 13 15 01
Key Executives for OptiNose AS
Chief Executive Officer and Director
Co-Founder and Chief Scientific Officer
Vice President of Operations & Program Management
Head of Device Development
Compensation as of Fiscal Year 2015.
OptiNose AS Key Developments
OptiNose AS Presents at 33rd Annual J.P. Morgan Healthcare Conference, Jan-12-2015 01:30 PM
Dec 18 14
OptiNose AS Presents at 33rd Annual J.P. Morgan Healthcare Conference, Jan-12-2015 01:30 PM. Venue: Westin St. Francis Hotel, San Francisco, California, United States. Speakers: Peter K. Miller, Chief Executive Officer and Director.
OptiNose Announces Management Changes
Jun 12 14
OptiNose announced three appointments to the company's senior management team. Ramona Lloyd, Ph.D. has joined the company as Vice President, Regulatory Affairs & Quality. Dr. Lloyd has held executive leadership positions in Regulatory Affairs and Quality with such companies as Sanofi-Aventis, Bristol Myers-Squibb, and Johnson & Johnson. Sheila Bergey has joined the company as Vice President, Operations & Program Management. Mrs. Bergey spent 25 years with Johnson & Johnson where she held leadership positions in Operations, Supply Chain, Change Management -- including Strategic Planning, Program Management, Information Technology, Process Excellence and Procurement. Terrence Terifay has joined the company as Senior Vice President and Chief Commercial Officer. Most recently, Mr. Terifay held commercial leadership positions at Mallinckrodt, including Vice President, Marketing and interim General Manager, Branded Specialty Pharmaceuticals.
Similar Private Companies By Industry
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
Most Searched Private Companies
Sponsored Financial Commentaries